Pfizer has responded to renewed questions about its COVID-19 vaccines, saying the shots met regulatory standards while acknowledging that data collection continued after rollout due to the urgency of the pandemic. The company noted the vaccines were developed at unprecedented speed using large clinical trials and real-world monitoring under regulatory oversight. The statement has revived debate about transparency, informed consent, and public trust. While many studies continue to support the vaccines’ effectiveness in reducing severe illness, critics say clearer early communication might have reduced confusion. Pfizer’s remarks highlight the ongoing challenge of balancing speed and caution in global health emergencies and the need to strengthen trust going forward.
Pfizer admits its Covid vaccines …
By admin
